Welcome to GLIA Diagnostics
Welcome to GLIA DiagnosticsWelcome to GLIA DiagnosticsWelcome to GLIA DiagnosticsSigned in as:
filler@godaddy.com
About Us
Who Are We
GLIA’s team of dedicated professionals, in collaboration with leading medical and scientific experts worldwide, is conducting clinical trials to validate novel biomarkers and assess their integration with complementary diagnostic modalities to advance the definitive diagnosis of traumatic brain injury (TBI), with a particular emphasis on mild TBI (mTBI) and concussion. Leveraging deep expertise across biomedical sciences, research, diagnostics, and commercial development, GLIA is uniquely positioned to deliver meaningful, transformative progress in this critical field.
Why Was GLIA Created
In many product development processes, work is carried out in silos, slowing overall progress—and medical research is no exception. At GLIA, we position ourselves as a central hub, uniting synergistic partners across Australasia and internationally. Through this collaborative approach, we seek to amplify the value of individual and collective discoveries, accelerating the delivery of an accurate diagnostic for traumatic brain injury (TBI).
Mission Statement
Our mission is to advance the understanding of brain injuries—particularly mild traumatic brain injury (mTBI)—through ongoing research and education. Ultimately, we are committed to rigorously validating a device that provides definitive diagnostic and prognostic insight, designed to complement and strengthen existing clinical assessments.